Almost a quarter of a million young people across England have already received their first dose of the MenB (meningococcal B) vaccine, as the NHS intensifies efforts to ensure students complete the two-dose course before heading to university this autumn.
New figures released by the NHS reveal that 246,089 doses of the MenB vaccine had been administered to eligible young people between the launch of the vaccination programme on 20 July 2026 and 31 August 2026. However, NHS leaders are warning that full protection against the potentially life-threatening infection requires a second dose at least 28 days after the first.
With Freshers' Week activities and moves into university halls of residence set to begin in the coming weeks, health officials are encouraging eligible students to book their follow-up appointment as soon as possible.
Research suggests that first-year university students face a significantly increased risk of contracting MenB, with those entering higher education around seven times more likely to develop the infection than their peers who do not attend university.
Dr Amanda Doyle, NHS National Director for Primary Care and Community Services, said:
“It’s fantastic that nearly a quarter of a million young people have already had their first dose of protection thanks to the support of thousands of community pharmacies, but freshers weeks and moving into halls and student houses can significantly increase the risk of exposure to MenB infection, so it’s vital to get fully shielded and book a second jab in the coming weeks.
“High street pharmacies up and down the country are making it easy and convenient to get jabbed, so if you’re eligible, please come forward and book as soon as possible to give yourself the best protection."

The NHS vaccination programme is being delivered through community pharmacies nationwide, allowing eligible young people to conveniently book appointments either through the NHS National Booking Service or directly with participating pharmacies.
Meningococcal B disease can progress rapidly and cause serious complications, including meningitis, an inflammation of the membranes surrounding the brain and spinal cord, and sepsis, commonly known as blood poisoning.
In severe cases, the infection can lead to life-changing disabilities such as hearing loss, brain injury and limb amputations. Tragically, it can also be fatal.
The bacteria responsible for MenB infection are spread through close contact with an infected person. Common routes of transmission include kissing, sharing drinks or vaping devices, and prolonged close contact in shared living environments such as student accommodation or family homes.
The success of the programme so far has been driven by the involvement of thousands of community pharmacies, which are helping to improve access to vaccination services for young people preparing to start university.
NHS leaders say that ensuring students receive both doses before beginning their studies remains a priority, particularly as large social gatherings and shared accommodation can create ideal conditions for the spread of MenB bacteria.
Eligible young people who have already received their first vaccination are being urged not to delay booking their second appointment, ensuring they have the strongest possible protection ahead of the new academic year.
Image credit: iStock
